{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:40:05Z","timestamp":1759347605288,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":1406,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.4103\/ijmm.ijmm_16_309","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T08:51:17Z","timestamp":1607331077000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Shahram","family":"Jalilian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahmoud","family":"Latifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoochehr","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Teimoori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azarakhsh","family":"Azaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Parsanahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamabas","family":"Kayedani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/ijmm.IJMM_16_309_bib1","doi-asserted-by":"crossref","first-page":"e32654","DOI":"10.5812\/hepatmon.32654","article-title":"Economic burden of hepatitis C virus infection in different stages of disease: A report from Southern Iran","volume":"16","author":"Zare","year":"2016","journal-title":"Hepat Mon"},{"key":"10.4103\/ijmm.IJMM_16_309_bib2","doi-asserted-by":"crossref","first-page":"e6151","DOI":"10.5812\/hepatmon.6151","article-title":"Real response to therapy in chronic hepatitis C virus patients: A study from Iran","volume":"12","author":"Namazee","year":"2012","journal-title":"Hepat Mon"},{"issue":"5 Suppl 1","key":"10.4103\/ijmm.IJMM_16_309_bib3","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology. Hepatology"},{"key":"10.4103\/ijmm.IJMM_16_309_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3748\/wjg.v22.i2.862","article-title":"Status of hepatitis C virus vaccination: Recent update","volume":"22","author":"Abdelwahab","year":"2016","journal-title":"World J Gastroenterology"},{"key":"10.4103\/ijmm.IJMM_16_309_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2014.09.021","article-title":"Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy","volume":"30","author":"Aziz","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.4103\/ijmm.IJMM_16_309_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/apt.12595","article-title":"Letter: The rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C \u2013 Authors\u2019 reply","volume":"39","author":"St\u00e4ttermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4103\/ijmm.IJMM_16_309_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.4103\/ijmm.IJMM_16_309_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00705-015-2364-8","article-title":"Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms","volume":"160","author":"Ling","year":"2015","journal-title":"Arch Virol"},{"key":"10.4103\/ijmm.IJMM_16_309_bib9","doi-asserted-by":"crossref","first-page":"e30780","DOI":"10.5812\/hepatmon.30780","article-title":"Efficacy and tolerability of peginterferon alpha-2a and peginterferon alpha-2b in Iranian patients with chronic hepatitis C","volume":"15","author":"Pouresmaeeli","year":"2015","journal-title":"Hepat Mon"},{"key":"10.4103\/ijmm.IJMM_16_309_bib10","first-page":"908","article-title":"Role of IL28B gene polymorphism in response to the standard of care treatment in Egyptian patients with chronic HCV genotype four","volume":"8","author":"Hendy","year":"2011","journal-title":"Life Sci J"},{"key":"10.4103\/ijmm.IJMM_16_309_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7124\/bc.0008B8","article-title":"Study on the IFNL4 gene ss469415590 variant in Ukrainian population","volume":"30","author":"Kucherenko","year":"2014","journal-title":"Biopolym Cell"},{"key":"10.4103\/ijmm.IJMM_16_309_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hep.23787","article-title":"Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy","volume":"52","author":"Harrison","year":"2010","journal-title":"Hepatology"},{"key":"10.4103\/ijmm.IJMM_16_309_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3350\/kjhep.2012.18.1.29","article-title":"The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection","volume":"18","author":"Kim","year":"2012","journal-title":"Korean J Hepatol"},{"key":"10.4103\/ijmm.IJMM_16_309_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2015.04.001","article-title":"Comparison of four methods of genotyping IL28B polymorphisms in chronic hepatitis C patients","volume":"220","author":"Delvaux","year":"2015","journal-title":"J Virol Methods"},{"key":"10.4103\/ijmm.IJMM_16_309_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/apt.12547","article-title":"Polymorphisms of interferon-\u03bb4 and IL28B \u2013 Effects on treatment response to interferon\/ribavirin in patients with chronic hepatitis C","volume":"39","author":"St\u00e4ttermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4103\/ijmm.IJMM_16_309_bib16","doi-asserted-by":"crossref","first-page":"e0117397","DOI":"10.1371\/journal.pone.0117397","article-title":"IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients","volume":"10","author":"Bordi","year":"2015","journal-title":"PLoS One"},{"key":"10.4103\/ijmm.IJMM_16_309_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/apt.12626","article-title":"Letter: Does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks? Authors\u2019 reply","volume":"39","author":"St\u00e4ttermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4103\/ijmm.IJMM_16_309_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.meegid.2016.01.020","article-title":"IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection","volume":"39","author":"Wu","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.4103\/ijmm.IJMM_16_309_bib19","first-page":"3","article-title":"Are the real HCV infection features in Iranian patients the same as what is expected?","volume":"5","author":"Alavian","year":"2005","journal-title":"Hepat Mon"},{"key":"10.4103\/ijmm.IJMM_16_309_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jceh.2016.07.001","article-title":"Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016","volume":"6","author":"Puri","year":"2016","journal-title":"J Clin Exp Hepatol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720302954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720302954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:16:19Z","timestamp":1759346179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720302954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0255085720302954"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_16_309","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_16_309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}